News Focus
News Focus
Replies to #54180 on Biotech Values
icon url

DewDiligence

11/02/07 7:59 AM

#54181 RE: ThomasS #54180

>ultimately, there will be fewer refractory patients to treat due to the improvement in treatment-naive.<

Quite so; however, until the bolus of existing treatment-refractory patients is whittled down, this setting will continue to be a large unmet need.